论文部分内容阅读
目的:评价头孢西丁与桂枝茯苓胶囊联用对盆腔炎患者治疗的临床疗效与价值。方法:将80例盆腔炎患者分为干预组和对照组(每组40例);干预组患者给予头孢西丁与桂枝茯苓胶囊治疗,对照组患者给予头孢西丁治疗;分析2组患者的疗效。结果:干预组患者临床治疗总有效率高于对照组,经统计学分析其差异有统计学意义(P<0.05)。结论:头孢西丁与桂枝茯苓胶囊用于治疗盆腔炎患者的疗效确切,可作为临床基础用药方案的治疗。
Objective: To evaluate the clinical efficacy and value of cefoxitin and Guizhi Fuling capsule in the treatment of pelvic inflammatory disease. Methods: Eighty patients with pelvic inflammatory disease were divided into intervention group and control group (40 cases in each group). Patients in the intervention group were treated with cefoxitin and Guizhi Fuling capsule, while those in the control group were given cefoxitin. Analysis of two groups of patients Efficacy. Results: The total effective rate of clinical treatment in intervention group was higher than that in control group, and the difference was statistically significant (P <0.05). CONCLUSION: Cefoxitin and Guizhi Fuling capsule are effective in treating patients with pelvic inflammatory disease and can be used as the basis of clinical medication regimen.